Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients

Lukas Baitsch(Ludwig Cancer Research), Petra Baumgaertner(Ludwig Cancer Research), Estelle Devêvre(Ludwig Cancer Research), Sunil K. Raghav(École Polytechnique Fédérale de Lausanne), Amandine Legat(Ludwig Cancer Research), Leticia Barba(Ludwig Cancer Research), Sébastien Wieckowski(University of Lausanne), Hanifa Bouzourène(University of Lausanne), Bart Deplancke(École Polytechnique Fédérale de Lausanne), Pedro Romero(Ludwig Cancer Research), Nathalie Rufer(Ludwig Cancer Research), Daniel E. Speiser(Ludwig Cancer Research)
Journal of Clinical Investigation
May 9, 2011
Cited by 820Open Access
Full Text

Abstract

In chronic viral infections, CD8⁺ T cells become functionally deficient and display multiple molecular alterations. In contrast, only little is known of self- and tumor-specific CD8⁺ T cells from mice and humans. Here we determined molecular profiles of tumor-specific CD8⁺ T cells from melanoma patients. In peripheral blood from patients vaccinated with CpG and the melanoma antigen Melan-A/MART-1 peptide, we found functional effector T cell populations, with only small but nevertheless significant differences in T cells specific for persistent herpesviruses (EBV and CMV). In contrast, Melan-A/MART-1-specific T cells isolated from metastases from patients with melanoma expressed a large variety of genes associated with T cell exhaustion. The identified exhaustion profile revealed extended molecular alterations. Our data demonstrate a remarkable coexistence of effector cells in circulation and exhausted cells in the tumor environment. Functional T cell impairment is mediated by inhibitory receptors and further molecular pathways, which represent potential targets for cancer therapy.


Related Papers